Tina Gullotta - Net Worth and Insider Trading
Tina Gullotta Net Worth
The estimated net worth of Tina Gullotta is at least $3,118 dollars as of 2024-12-27. Tina Gullotta is the VP, Finance of Sunesis Pharmaceuticals Inc and owns about 586 shares of Sunesis Pharmaceuticals Inc (SNSS) stock worth over $3,118. Details can be seen in Tina Gullotta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tina Gullotta has not made any transactions after 2020-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tina Gullotta
Tina Gullotta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tina Gullotta owns 2 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , and Viracta Therapeutics Inc (VIRX) .
Click here to see the complete history of Tina Gullotta’s form 4 insider trades.
Insider Ownership Summary of Tina Gullotta
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SNSS | Sunesis Pharmaceuticals Inc | 2020-05-29 | VP & Finance |
VIRX | Viracta Therapeutics Inc | 2020-04-28 | VP & Finance |
Tina Gullotta Latest Holdings Summary
Tina Gullotta currently owns a total of 1 stock. Tina Gullotta owns 586 shares of Sunesis Pharmaceuticals Inc (SNSS) as of May 29, 2020, with a value of $3,118.
Latest Holdings of Tina Gullotta
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SNSS | Sunesis Pharmaceuticals Inc | 2020-05-29 | 586 | 5.32 | 3,118 |
Holding Weightings of Tina Gullotta
Tina Gullotta Form 4 Trading Tracker
According to the SEC Form 4 filings, Tina Gullotta has made a total of 1 transactions in Sunesis Pharmaceuticals Inc (SNSS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sunesis Pharmaceuticals Inc is the acquisition of 171 shares on May 29, 2020, which cost Tina Gullotta around $1,980.
Insider Trading History of Tina Gullotta
- 1
Tina Gullotta Trading Performance
GuruFocus tracks the stock performance after each of Tina Gullotta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tina Gullotta is -25%. GuruFocus also compares Tina Gullotta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tina Gullotta within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tina Gullotta's insider trading performs compared to the benchmark.
Performance of Tina Gullotta
Tina Gullotta Ownership Network
Tina Gullotta Owned Company Details
What does Sunesis Pharmaceuticals Inc do?
Who are the key executives at Sunesis Pharmaceuticals Inc?
Tina Gullotta is the VP & Finance of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , See Remarks Judith A. Fox , and See Remarks William P. Quinn .
Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sunesis Pharmaceuticals Inc Insider Transactions
Tina Gullotta Mailing Address
Above is the net worth, insider trading, and ownership report for Tina Gullotta. You might contact Tina Gullotta via mailing address: Sunesis Pharmaceuticals,inc, 395 Oyster Point Blvd., Suite 400, South San Francisco Ca 94080.